Nuo Therapeutics, Inc.
AURX
$2.26
$0.010.29%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.43M | -2.47M | -2.36M | -2.32M | -2.48M |
| Total Depreciation and Amortization | 142.90K | 122.20K | 101.40K | 96.30K | 94.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 103.90K | 88.00K | 52.90K | 32.50K | 137.70K |
| Change in Net Operating Assets | 1.25M | 1.55M | 539.50K | -36.70K | -164.90K |
| Cash from Operations | -932.80K | -713.80K | -1.67M | -2.23M | -2.41M |
| Capital Expenditure | -231.60K | -382.50K | -384.90K | -155.00K | -155.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -231.60K | -382.50K | -384.90K | -155.00K | -155.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 995.40K | 939.50K | 1.74M | 1.74M | 2.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 995.40K | 939.50K | 1.74M | 1.74M | 2.61M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | -169.10K | -156.70K | -310.60K | -644.90K | 46.30K |